Proteome Sciences plc (PMSNF)
USD 0.03
(7.14%)
USD 0.03
(7.14%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -1.13 Million USD | -155.0% |
| 2022 | 1.83 Million USD | 132.86% |
| 2021 | 452 Thousand USD | 3.76% |
| 2020 | 581 Thousand USD | 93.75% |
| 2019 | 336 Thousand USD | 133.64% |
| 2018 | -1.14 Million GBP | 26.82% |
| 2017 | -1.47 Million GBP | 24.47% |
| 2016 | -2.13 Million GBP | 34.14% |
| 2015 | -2.68 Million GBP | -11.23% |
| 2014 | -3.57 Million GBP | -11.74% |
| 2013 | -3.2 Million GBP | 33.68% |
| 2012 | -4.82 Million GBP | -17.45% |
| 2011 | -4.11 Million GBP | -181.33% |
| 2010 | 5.05 Million GBP | 236.32% |
| 2009 | -3.7 Million GBP | 9.45% |
| 2008 | -4.09 Million GBP | 17.8% |
| 2007 | -4.98 Million GBP | 12.26% |
| 2006 | -5.67 Million GBP | 7.91% |
| 2005 | -6.16 Million GBP | -41.44% |
| 2004 | -5.12 Million GBP | 28.29% |
| 2003 | -6.74 Million GBP | -62.52% |
| 2002 | -3.74 Million GBP | -92.14% |
| 2001 | -1.94 Million GBP | -46.61% |
| 2000 | -1.32 Million GBP | -14.58% |
| 1999 | -1.15 Million GBP | 35.32% |
| 1998 | -1.79 Million GBP | -24.44% |
| 1997 | -1.44 Million GBP | 6.92% |
| 1996 | -1.54 Million GBP | 0.0% |
| 1994 | -24 Thousand GBP | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -1.61 Million USD | 0.0% |
| 2023 Q2 | 158.66 Thousand USD | 0.0% |
| 2023 FY | - USD | -155.0% |
| 2023 Q4 | -1.6 Million USD | 0.0% |
| 2022 FY | - USD | 132.86% |
| 2022 Q2 | 640.19 Thousand USD | 0.0% |
| 2022 Q4 | 1.93 Million USD | 0.0% |
| 2021 FY | - USD | 3.76% |
| 2021 Q2 | -269.38 Thousand USD | 0.0% |
| 2021 Q4 | 1.1 Million USD | 0.0% |
| 2020 Q4 | 1.27 Million USD | 0.0% |
| 2020 FY | - USD | 93.75% |
| 2020 Q2 | -322.49 Thousand USD | 0.0% |
| 2019 Q4 | 805.44 Thousand USD | 0.0% |
| 2019 FY | - USD | 133.64% |
| 2019 Q2 | -307.99 Thousand USD | 0.0% |
| 2018 FY | - GBP | 26.82% |
| 2017 FY | - GBP | 24.47% |
| 2016 FY | - GBP | 34.14% |
| 2015 FY | - GBP | -11.23% |
| 2014 FY | - GBP | -11.74% |
| 2013 FY | - GBP | 33.68% |
| 2012 FY | - GBP | -17.45% |
| 2011 FY | - GBP | -181.33% |
| 2010 FY | - GBP | 236.32% |
| 2009 FY | - GBP | 9.45% |
| 2008 FY | - GBP | 17.8% |
| 2007 FY | - GBP | 12.26% |
| 2006 FY | - GBP | 7.91% |
| 2005 FY | - GBP | -41.44% |
| 2004 FY | - GBP | 28.29% |
| 2003 FY | - GBP | -62.52% |
| 2002 FY | - GBP | -92.14% |
| 2001 FY | - GBP | -46.61% |
| 2000 FY | - GBP | -14.58% |
| 1999 FY | - GBP | 35.32% |
| 1998 FY | - GBP | -24.44% |
| 1997 FY | - GBP | 6.92% |
| 1996 FY | - GBP | 0.0% |
| 1994 FY | - GBP | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| American Bio Medica Corporation | -1.16 Million USD | 2.236% |
| Arrayit Corporation | -3.07 Million USD | 63.054% |
| Atlantic International Corp. | -5.38 Million USD | 78.904% |
| Biocept, Inc. | -30.24 Million USD | 96.24% |
| Bioqual, Inc. | 3.03 Million USD | 137.497% |
| CardioGenics Holdings Inc | -757.37 Thousand USD | -50.124% |
| DermTech, Inc. | -97.89 Million USD | 98.839% |
| Global WholeHealth Partners Corporation | - USD | Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 2.91 Billion USD | 100.039% |
| HTG Molecular Diagnostics, Inc. | -20.24 Million USD | 94.383% |
| iMD Companies, Inc. | -154.65 Thousand USD | -635.166% |
| IDenta Corp. | 71.58 Thousand USD | 1688.277% |
| Interpace Biosciences, Inc. | 3.83 Million USD | 129.633% |
| Integrative Health Technologies, Inc. | 38.69 Thousand USD | 3038.744% |
| InVitro International | 6680.00 USD | 17120.958% |
| Lumos Diagnostics Holdings Limited | -5.43 Million USD | 79.084% |
| Many Bright Ideas Technologies Inc. | -12.13 Thousand USD | -9270.364% |
| Medical Imaging Corp. | -896.74 Thousand USD | -26.792% |
| NovelStem International Corp. | -3.78 Million USD | 69.967% |
| Optigenex Inc. | -1.18 Million USD | 4.19% |
| PharmChem, Inc. | 1.05 Million USD | 207.894% |
| Response Genetics, Inc | -19.66 Million USD | 94.218% |
| Rennova Health, Inc. | -234.81 Thousand USD | -384.211% |
| RushNet, Inc. | -614.85 Thousand USD | -84.923% |
| ScreenPro Security Inc. | -3.43 Million USD | 66.898% |
| Stella Diagnostics Inc. | -5.7 Million USD | 80.079% |
| StageZero Life Sciences Ltd. | -10.27 Million USD | 88.929% |
| Todos Medical Ltd. | -9.39 Million USD | 87.897% |